Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

ORMP Oramed Pharmaceuticals Inc

2,09

-0,09 (-4,13%)

Zuletzt aktualisiert: 21:53:14

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Oramed Pharmaceuticals (NASDAQ:ORMP)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Oramed Pharmaceuticals Charts.

Oramed Pharmaceuticals (NASDAQ:ORMP)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Oramed Pharmaceuticals Charts.

News Oramed Pharmaceuticals Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 6 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation
Dienstag 19 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mittwoch 6 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 20 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Oramed Letter to Shareholders
Dienstag 20 Februar 2024 (4 Monate vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 30 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 23 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 19 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 8 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 8 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 8 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Weitere Oramed Pharmaceuticals Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen